key: cord-0834305-qv6dzv2h
authors: Blanchi, Sophie; Torreggiani, Massimo; Chatrenet, Antoine; Fois, Antioco; Mazé, Béatrice; Njandjo, Linda; Bianco, Giovanna; Lepori, Nicola; Pili, Alessio; Michel, Pierre-Antoine; Sileno, Giuseppe; Arazzi, Marta; Esposito, Vittoria; Pani, Antonello; Versino, Elisabetta; Esposito, Ciro; Fessi, Hafedh; Cabiddu, Gianfranca; Piccoli, Giorgina Barbara
title: COVID-19 vaccine hesitancy in patients on dialysis in Italy and France.
date: 2021-09-08
journal: Kidney Int Rep
DOI: 10.1016/j.ekir.2021.08.030
sha: cc0a2dbe46b2d954e5c43da031400aae70c7d3b6
doc_id: 834305
cord_uid: qv6dzv2h

INTRODUCTION: Patients on dialysis (HDP) are a category at high risk from COVID-19 and thus a high-priority group for vaccination. COVID-19 vaccine hesitancy has been a concern since the availability of the first vaccine. The objective of this study was to determine hesitancy rates and factors associated with hesitancy towards COVID-19 vaccination in HDP. METHODS: HDP were surveyed with an ad hoc questionnaire in four large dialysis facilities in Europe: Le Mans and Paris, in France, Cagliari and Pavia, in Italy. The questionnaire explored different domains associated with vaccine hesitancy, such as perception of disease severity, sources of information about the vaccine and the disease, and confidence in the healthcare system. RESULTS: 417 patients (average age 69, 60% men) agreed to answer the questionnaire. Hesitancy was associated with younger age (p 0.003), lower perception of disease severity (<0.001) and vaccine efficacy (p<0.001), lower trust in vaccination (p<0.001) and in the healthcare system and scientists (p<0.001) in the univariate analysis. In the multivariate models, concerns about side effects (p 0.004) and vaccine efficacy (<0.001) and living in France (p 0.04) remained associated with higher vaccine hesitancy, while having received an influenza vaccine (p 0.032) and trusting scientists (p 0.032) were associated with a more positive attitude towards vaccination. CONCLUSIONS: HDP have a good understanding of the risks associated with COVID-19. Vaccine hesitancy was not associated with educational level, age or gender but rather with lack of confidence in vaccine efficacy and concerns about safety. HDP were quite skeptical about the healthcare system but generally trusted scientists.

The COVID-19 epidemic had highlighted the fragility of some groups, in particular elderly and high-comorbidity individuals. 1 The fragility of patients on dialysis, combining immunodepression, high morbidity and older age is well acknowledged. During the first year of the pandemic, their fragility, plus the need for regular visits to often crowded dialysis wards, resulted, in a high rate of infection in patients on dialysis (a cumulative incidence of over 14%

in France and in Italy), with high mortality (between 15% and 20% of all cases). [2] [3] [4] On April 8, 2021, the European Medicines Agency (EMA) granted conditional marketing authorization to four COVID-19 vaccines: two mRNA vaccines, Comirnaty (Pfizer/BioNTech) and COVID-19 Vaccine Moderna, and two non-replicative viral vector vaccines, Vaxzevria (Astra Zeneca) and COVID-19 Vaccine Janssen. Starting in January 2021, patients on dialysis in France were identified by the Haute Autorité de Santé (HAS) as a priority population for vaccination against SARS-CoV-2. The HAS in France and Italy's Ministero della Salute recommends prioritizing the vaccination for people at a very high risk of death, including dialysis and kidney transplant patients, regardless of their age. 5, 6 The use of mRNA vaccines is preferred for these patients. COVID-19 vaccines are free of charge in both countries.

However, the availability of vaccines and their acknowledged priority by the health authorities has not guaranteed vaccine acceptance.

In 2019, the WHO identified vaccine hesitancy as one of the ten most serious threats to global health. 7 Vaccine hesitancy is defined as "delay in acceptance or refusal of vaccines despite availability of vaccine services". This phenomenon is of particular concern in Western Europe.

Several factors have been identified as being associated with COVID-19 vaccine acceptance in the general population: perception of the seriousness of the infection, perception of the risk of infection for oneself and one's family, trust in the healthcare system, trust in the J o u r n a l P r e -p r o o f information given by doctors, trust in vaccine research, vaccine safety, vaccine effectiveness, having received a flu vaccine, male gender, white ethnicity, educational level, income level, urban versus rural living, older age. [8] [9] [10] [11] [12] [13] [14] People with comorbidities at risk of severe were found more likely to accept a COVID-19 vaccine. 12, 13 However, COVID-19 vaccine refusal remains high: in a recent US study, less than half the respondents between 18 and 64 years of age with underlying medical conditions replied that they would be likely to receive a COVID-19 vaccine. 14 To date, only one study on COVID-19 vaccine hesitancy in patients on dialysis has been conducted. Done in the United States, its findings related hesitancy to younger age, female gender and some ethnic groups. 15 In-depth knowledge about the perceived barriers to vaccination is however crucial for acceptance, and since there is likely to be a significant degree of vaccine hesitancy in the dialysis population, everything possible should be done to obtain a high rate of vaccine coverage and protect this community.

Given that this is so, we designed this international multicenter study to assess COVID-19 vaccine hesitancy rates in patients on dialysis in four large dialysis facilities in Italy and France, with one center in each country in a rural area and one in a city, in order to identify factors associated with vaccine acceptance and hesitancy.

Le Mans. Centre Hospitalier du Mans (CHM), one of the three largest non-university hospitals in France, has about 1700 beds, 500 of them in geriatric units and about 300 for different medical specialties (20 in nephrology) . Le Mans has about 150,000 inhabitants, with approximately another 150,000 people living in its suburbs; CHM serves a population of about 800,000 inhabitants. Two dialysis facilities run by a non-profit association (ECHO) are present in the area but nephrology beds are only available at CHM. Patients on peritoneal dialysis are managed conjunctly, and were not included in the present survey. The dialysis ward has 25 beds. These are occupied by chronic patients on dialysis, patients with acute kidney injury (AKI) and patients from out-of-hospital centers who need to be hospitalized. The pool of patients on chronic hemodialysis ranges from 95 to 110, depending on the incidence of kidney transplantation, deaths and transfers. In keeping with the indications of the French Society of Nephrology (Société Francophone de Néphrologie, Dialyse et Transplantation, SFNDT), outof-hospital dialysis is widely used and only cases posing particular clinical, attitudinal or psychological problems are managed in the hospital. Hence the population studied is a large sample of the most difficult patients treated in the area. The ratio between cases treated at CHM and those treated at the non-profit association is around 1:6.

All physicians without contraindications and all the nurses working in dialysis (7 nephrologists and all the nurses) had received at least one dose of the vaccine at the time the survey began.

Cagliari. The study was conducted at Azienda Ospedaliera Brotzu, the largest hospital in Sardinia, Italy's largest island. The hospital has about 677 beds (24 in the nephrology ward) and a transplant center, performing 35-40 kidney grafts per year. Cagliari has a population of about 150,000 inhabitants, which rises to 420,000 if those living in districts surrounding the city are counted, and the entire area Ospedale Brotzu serves has a population of about 800,000.

J o u r n a l P r e -p r o o f Nephrology beds are only available in the hospital. A network of public out-of-hospital dialysis facilities provides treatment for patients with lower comorbidity, in keeping with Italian practice. The ratio between patients treated at Ospedale Brotzu and those receiving dialysis in out-of-hospital settings is around 1:6.

The dialysis unit has 26 beds dedicated to chronic patients and eight for patients from other units with AKI or CKD, requiring hospitalization. The pool of patients on chronic treatment ranges from 90 to 100, depending on kidney transplantation, deaths and transfers. Between 50 and 55 peritoneal patients on dialysis are also followed in the unit (monthly clinical visits in the center). All physicians and 87% of the nurses working in dialysis had received at least one dose of the vaccine when the survey began. 

In the four centers in which the study was carried out, all patients on chronic dialysis without dementia and without language barriers that would impair basic comprehension of the questions, were asked to participate. All patients were outpatients and none was hospitalized when the questionnaire was administered. Each center distributed the questionnaire according to their usual way of proposing questionnaires to patients. In detail, in Le Mans the questionnaires were introduced by the caregivers and patients were free to complete them in the dialysis ward or at home, or, alternatively, to complete them with the help of a clinical research assistant, during, J o u r n a l P r e -p r o o f before or after their dialysis session. The last of these was the preferred modality: due to advanced age and social isolation, many patients had become accustomed to completing questionnaires (mainly periodic assessments of their quality of life) in the unit with help from nurses or clinical research assistants, In Le Mans, the questionnaires, distributed about three weeks before the start of the vaccination campaign, were the first step in an educational program whose target was to give patients information on COVID-19 vaccines.

In Cagliari and Pavia the questionnaires were proposed by the senior physician and completed by patients, generally with some help from the residents. In both settings, the questionnaire was administered four to six weeks before vaccination had started. In Cagliari patients had occasionally been asked in the past to participate in observational studies requiring the completion of a questionnaire, and in these cases the preferred way to answer was with assistance from caregivers. In Paris, the questionnaire was proposed just a few days before the start of the vaccination program in the dialysis ward. Patients there had never before been asked to participate in a survey. The questionnaires were introduced by residents or in the case of home hemodialysis patients, by nurses. Although patients were given the choice of being given assistance to complete the questionnaire during their dialysis session, the majority preferred to answer at home, and return the completed survey afterwards.

In all four participating centers, patients' general data are stored in dedicated databases. The following information was gathered for the current analysis: age, gender, country of birth, native language(s), educational level, working status, cause of end stage kidney disease, Charlson comorbidity index (CCI), date of start of dialysis, dialysis vintage, previous transplantation, type of dialysis, number of dialysis sessions per week (hemodialysis) or of daily exchanges in peritoneal dialysis.

Questionnaires A team of infectiologists and nephrologists at CHM in Le Mans designed a questionnaire to collect information on whether patients on dialysis intended to be vaccinated and identify obstacles to vaccination (available in the supplementary material). The development of this questionnaire was based on a literature review of identified barriers to vaccination in general and to vaccination against SARS-CoV-2. [8] [9] [10] [11] [12] [13] [14] 16 Besides the respondent's decision on whether or not they would receive the vaccine against COVID-19 (yesno -uncertain), the questions regarded the following topics: acknowledgement of the severity of COVID-19; amount of information received from the dialysis team and from the media; fear of side effects from the vaccine; confidence in the healthcare system; confidence in the efficacy of the vaccine. Whether or not a respondent had previously received an anti-influenza vaccine was also recorded.

The visual analogue questions were analyzed as actual number reported, and summarized in three major scores: low 0-3; medium 4-6; high 7-10. 17 The analysis of the actual prevalence of anti COVID-19 vaccination (first dose considered) was performed considering only individuals who did not have contraindications and were alive, and were being treated in the same center as at the time of their first vaccine dose.

Statistical analysis was performed with SPSS v.14 (IBM corp., Armonk, NY, USA) and JASP v.0.11.1 (JASP Team, Amsterdam, NL). Descriptive analysis was conducted as appropriate; the Shapiro-Wilk test was used to verify the normality distribution of the data, and the Leven test was used to verify homoscedasticity. Depending on distribution of the data, the unpaired T-test was used to compare two groups (e.g. acceptance vs non acceptance of vaccination), while the ANOVA test was used to compare three or more groups (e.g. comparing the study centers).

Otherwise, the Mann-Whitney test was applied to compare two groups, while the Kruskal-Wallis test was used for additional comparisons.

Categorial results were presented as size with a percentage and compared with the Chi-squared test or the Fisher Exact test for small subgroups.

Univariate logistic regressions were performed to test the outcome of refusal to be vaccinated against COVID-19 in comparison to baseline data and answers to questions on the questionnaire. ROC curves, together with Youden's index, were used to identify the best cut-point for the continuous items associated with the outcome (age only).

The outcome "refusal to be vaccinated against COVID-19" was tested in a multivariate logistical regression analysis. The explanatory variables were chosen according to their clinical relevance or to the significance in the univariate analysis. At baseline they were the following:

age (dichotomized at Youden index, 64 years), gender (female or male), country (Italy or France). As for the questionnaire entries, due to the high degree of correlation between questions inquiring about a specific aspect of vaccine hesitancy (fear of the disease or acknowledgement of its severity; confidence in the healthcare system and scientists; information received; concerns about safety; trust in the efficacy of the COVID-19 vaccine and vaccines in general, and previous vaccination against influenza), one sample question was chosen on the basis of its higher statistical hazard ratio or clinical relevance. The explanatory variables were dichotomised at both the lowest values (scores 0-3) and the highest ones (scores 7-10), thus building two separate models.

A two-tailed alpha risk at 5% was considered statistically significant.

The study was performed in compliance with the Declaration of Helsinki.

Patient participation was voluntary. Permission for publication of the anonymous questionnaires and of anonymous general clinical data was obtained when a completed questionnaire was returned. The study was approved by the ethics committee at CHM in April 2021, and the ethics committees at the University of Cagliari and the Maugeri Institute were also notified that the study was being conducted in April 2021.

The baseline data of the patients who answered the questionnaires are reported in Table   1 , and the flow chart of the study is presented in Figure 1 , while data on the patients who did not answer the questionnaires and their reasons for not participating are reported in Supplementary Table 1. Supplementary Figure 1 shows the study flow chart of each participating center.

In the context of a high response to the questionnaires (overall above 85%), some baseline differences emerged: the highest retrieval of questionnaires was in Italy (Cagliari and Pavia), and the lowest in Paris, a center that differs in significant respects from the others in the study. The median age is lower, to some extent reflecting the high number of patients on home hemodialysis. Educational level is also higher, as is the prevalence of patients who were born in a country other than their one of residence (40%, double the percentage in Le Mans, while Pavia and Cagliari had significantly lower percentages of foreign-born patients). In keeping with differences in age, the prevalence of patients working was higher and the CCI was lower in Paris compared with the other settings of study.

Reasons for declining to answer the survey were also different: language barriers and dementia were the main ones in Italy while in Paris refusal was more often due to lack of interest and/or lack of confidence in why the survey was being conducted (Supplementary Table 1 Figure 2 shows the details of each answer to the questionnaire.

In the context of a perception of a high risk of being infected by SARS-CoV-2, the appreciation of the severity of the disease was high (median score 9), without differences in the four settings. Patients reported they had been extensively informed by the media about the disease (median score 7), but had received less information about the vaccine (median score 6).

Delivery of information from the dialysis team was reported differently, with the lowest score in Le Mans, where the administration of the questionnaire preceded the delivery of capillary oral and written information on vaccination (including timing and side effects). The highest scores were recorded in Paris, where the questionnaires were proposed almost at the same time as the vaccination campaign began. Overall, patients stated they were favorable to vaccination, as a general concept (median score 10), but their confidence in the efficacy of the COVID-19

vaccine was a good deal lower (median score 7).

Confidence in the way the healthcare system is managing the crisis was not high in all centers (median score 5), while patients had more trust in scientists (median score 7), with the highest score in Le Mans (8) and the lowest in Paris (6) . While the risk of side effects from the vaccine appears to be well acknowledged (median score 5), this did not seem to frighten patients on dialysis, who were not particularly worried about their personal wellbeing (median score 3).

In the two French centers, the answers to questions regarding the choice of COVID-19 vaccine were straightforward, and only a minority of the patients stated they were uncertain, while in Italy the number of uncertain individuals was higher than the number of refusals.

Interestingly, the prevalence of vaccine hesitancy for COVID-19 was significantly lower than those who indicated they would refuse to have an influenza vaccine (18.9% versus 35.7% p<0.001).

Relationship between vaccine hesitancy, baseline data and response to the questionnaire: univariate analysis. Table 3 reports the results of the logistic regression correlating refusal to be vaccinated, as stated on the questionnaire, with clinical and demographic features and with answers to other questions, dichotomized as low versus all other scores.

The analysis confirms the importance of context: the odds ratio (OR) for respondents living in France refusing vaccination against SARS-COV-19 is 3.505; being over 64 years of age is associated with lower vaccine hesitancy (OR: 0.248).

Conversely, it was found that gender, renal replacement therapy vintage, having been exposed to immunosuppessive treatments (because of glomerulonephritis or transplantation), educational level, or being born in a country other than the one currently resided in had no effect on answers to the questionnaire.

Considering that the information delivered from the media was not sufficient was associated with a higher probability of refusing vaccination, differently from the amount of information delivered by the dialysis team. Some points deserve to be underlined: the importance of the family in patients' decisions, which true for both large extended families (gypsies), and smaller nuclear families (parents, children and grandchildren); the idea that the attention the disease has received is "much ado about nothing"; the fear that the vaccine is not safe and that, therefore, for the moment it may be wise to wait. A lack of confidence emerges from some answers, while the importance of the dialysis team is also clearly shown.

Relationship between vaccine hesitancy, baseline data and response to the questionnaire: multivariate analyses.

In the multivariate analysis (Tables 4 and 5) , vaccine hesitancy was strongly correlated with country of study, while age had little statistical significance; confidence in the efficacy of the vaccine and having had an anti-influenza vaccine were strongly associated with vaccine hesitancy. Concerns about safety was an important modulator of choice. High confidence in scientists maintained its statistical significance in the analysis, while the acknowledgement of the potential severity of the disease was not associated with vaccine hesitancy in either models.

The residual analysis demonstrated the goodness of fit of the statistical models used (Supplementary Figure 3 and 4) .

The flowchart of the study population presented in Figure 1 , and in Supplemental Figure 1 for the individual centers, shows the relationship between the choices indicated in the questionnaires and actual administration of the vaccine, both for patients who answered and J o u r n a l P r e -p r o o f Discussion This study, analyzing the answers to a questionnaire designed to assess vaccine hesitancy in more than 400 patients on dialysis, found a relatively low overall prevalence of vaccine hesitancy in the dialysis population, defined as present refusal to undergo COVID-19 vaccination in individuals without contraindications. Only 11.3% of the patients who answered the dedicated questionnaire stated they did not intend to have the COVID-19 vaccine. There were, however significant differences, as the percentage ranged from 4.6% (Pavia, industrial setting, northern Italy) to 25% in Paris, France ( Table 1 ). The actual figures (vaccines administered) were similar (Figure 1, Supplementary Figure 1 ), thus also indirectly validating this type of questionnaire for assessing patients' opinions. However, a questionnaire such as ours probably underestimates vaccine hesitancy, as those who refused to answer it were more likely not to have the COVID-19 vaccine (figure 1). These differences are consistent with previous studies of the general population which found high vaccine hesitancy in France 8, 9 . These differences were at least partly expected on account of the different degree of penetrance of COVID-19 vaccine among healthcare workers, which was reported as significantly lower in France, in particular in Paris 18-20 , than in Italy. In fact, in 2016, France and Italy were the two countries with the highest rates of vaccine safety skepticism 21 A European study conducted in April 2020 in seven countries showed that France had the largest proportion of the population opposed to a COVID-19 vaccine (10%) and the largest group of people who had not decided whether or not they would be vaccinated (28%). Denmark and the UK were the countries with the largest proportion of respondents who stated they would be willing to be vaccinated (80%).

In Italy, this rate was 74% 8 Similarly, in an international study conducted in June 2020 in 19 countries, when asked "If a COVID-19 vaccine is proven safe and effective and is available, I will take it", only 58.89% of participants in France answered that they would, versus 70.79% in Italy. 9 It is noteworthy, however, that the percentage of COVID-19 vaccination in the four J o u r n a l P r e -p r o o f study centers was higher than the national average for healthcare workers (100% of the doctors and 100%, 80%, 87% and 96% of the nurses in Le Mans, Paris, Cagliari and Pavia, respectively). Due to a high incidence of SARS CoV2 infection in patients on dialysis 2, 4 , dialysis teams often had to care for COVID-19 patients, which may explain this difference. 22 Differently from what has been described in the overall population, gender and educational level did not correlate with vaccine refusal; older age was associated with lower vaccine refusal, but the difference emerged only in the univariate analysis (Table 3) . Likewise, in the subset of the population that answered the questionnaires (overall more than 85%), being born in a country other than the one of residence (chosen as a marker of belonging to an ethnic minority) did not affect vaccine acceptance (Table 3) , contrary to what has been reported for the general population. [23] [24] [25] [26] [27] [28] Furthermore, in a context of low vaccine hesitancy, answers were not modulated by dialysis vintage, or by exposure to immunosuppressive drugs (because of previous transplantation or glomerular and systemic kidney disease).

Patients were well aware of the risks and severity of COVID-19. The question "Do you think that COVID-19 is a serious disease?" recoded a median score of 9, without differences between centers (table 2). This perception of the seriousness of the infection was much higher than that of the general population and may explain the low rate of vaccine refusal, as it is a factor associated with better acceptability of vaccination. 10, 12, 23 Furthermore, patients were not worried about vaccine availability (median score 2), probably because in all centers the questionnaire was linked to the vaccination campaign, and, in the context of generic confidence in vaccines (median score 10), the majority of the patients were not extremely concerned about safety (median score 3), while they were, in general, aware of the risks of side effects (median score 5) ( Table 3) . (Table 1 ). This can be explained by a lower perceived severity of seasonal influenza than COVID-19 by patients on dialysis. 30 Confidence in the healthcare system was relatively low in all settings (median score 5, Table   2 ). However, confidence in scientists (a generic term chosen to avoid being intrusive and clearly alluding to the healthcare team) was higher (median score 7, Table 2 ) and both were correlated with vaccine hesitancy in the univariate analysis, while in the multivariate analysis only high confidence in the scientific community was associated with low probability of refusing the COVID-19 vaccine.

We consider that this is one of the most interesting findings of our study, suggesting that confidence in the scientific community is more important than having been given information by the media or by a healthcare team. In this regard, while we agree that from an ethical point of view, information campaigns are important for supporting choices, we have come to think that they may be less relevant than confidence in the role of science, a term that was chosen to indirectly allude to the medical community. Lack of confidence in the healthcare system was J o u r n a l P r e -p r o o f in fact identified as a major determinant of vaccine hesitancy in the case of COVID-19 and of other vaccines 10, 19, [26] [27] [28] , and the low vaccine acceptance of healthcare workers in some "difficult" settings may also be evidence of this attitude.

In fact vaccine hesitancy was not associated with fear of COVID-19, nor with generic high hesitancy about vaccines; patients on dialysis, probably like most of our physicians, focused on the efficacy and security of this specific vaccine, suggesting that educational campaigns should be specifically addressed to these two points.

Interestingly, one third of patients who expressed they refusal to vaccination, eventually got vaccinated, suggesting that the personal belief expressed in the beginning was not always consistent with the final decisions. However the limited number of patients who changed their decision after completing the questionnaire is too small to draw any conclusion.

The findings of a similar study, recently conducted in 150 dialysis centers with 1515 patients in the United States, were significantly different from ours. 15 Younger patients, Blacks, Native Americans, Pacific Islanders and women were more likely to state that they would not be vaccinated. However, the authors did not correlate vaccine hesitancy with the actual percentage of patients in their sample who were subsequently vaccinated. Moreover, only 14% of the eligible participants answered the survey in the USA, while our sample accounts for almost 88% of the entire dialysis population in the four participating centers.

Our study needs to be contextualized. It was performed before the controversy over the side effects of COVID-19 vaccines arose. Therefore the responses might have been different had it been done later. Furthermore, it has several limitations: like all cross-sectional studies, it only makes it possible to establish associations, and cause-effect relationships are only hypothetical.

While it enrolled more than 400 patients on dialysis, the number may be too low to highlight other important differences relevant to the rollout of a vaccine campaign for patients on dialysis.

Furthermore, many of the answers are mutually related, and therefore a mathematical model J o u r n a l P r e -p r o o f may fail to identify the leading ones, and only suggest which associations may be of interest for understanding the phenomenon of vaccine hesitancy in dialysis and for suggesting targeted interventions. In addition, questionnaires were administered at different times in the four dialysis facilities, between January and March, and the perception of vaccine efficacy and safety may change over time as new information became available. Although questions referred to healthcare workers and the healthcare system in general, the help of caregivers could have had an impact on patients' answers. Finally, no explanation on the reason for vaccine hesitancy was available in cases who did not fill the questionnaire. Within these limits, our study, the first one of its type performed in Europe, showed that our dialysis population is an interesting microcosm whose answers can help us improve care and mutual confidence in the long term, a major potential reinvestment of this difficult experience.

Patients on dialysis have a keen understanding of COVID-19 risks. In the context of low, but variable vaccine hesitancy, this attitude is not linked to educational level, age, or gender.

Vaccine hesitancy is closely associated with lack of confidence in vaccine efficacy, and concerns about safety. Patients on dialysis are quite skeptical about the healthcare system, but generally trust scientists. The high acceptance of COVID-19 vaccination may be linked to this trust, and this pattern should prompt us to reflect on the fact that building a system of mutual trust is more important than giving detailed information when advising patients on important decisions, such as whether or not to be vaccinated against COVID-19.

All authors have nothing to disclose J o u r n a l P r e -p r o o f figure 3 for residuals of the model 

Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy

Situation de l'épidémie de Covid19 chez les patients dialysés et greffés rénaux en France au 12 avril 2021. Bulletin numéro 45 du registre REIN, Agence de la biomédecine

Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy

Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology

Association of low-protein supplemented diets with fetal growth in pregnant women with CKD

Incremental dialysis in ESRD: systematic review and meta-analysis

Ready to Change: Attitudes of an Elderly CKD Stage 3-5 Population towards Testing Protein-Free Food

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

A global survey of potential acceptance of a COVID-19 vaccine

Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines (Basel) 2020

Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics

Social Patterning and Stability of Intention to Accept a COVID-19 Vaccine in Scotland: Will Those Most at Risk Accept a Vaccine? Vaccines

COVID-19 vaccination intent, perceptions, and reasons for not vaccinating among groups prioritized for early vaccination -United States

SARS-CoV-2 Vaccine Acceptability in Patients on Hemodialysis: A Nationwide Survey

Current tools available for investigating vaccine hesitancy: a scoping review protocol

How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance

Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a crosssectional survey

Vaccine hesitancy among general practitioners in Southern France and their reluctant trust in the health authorities

Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy

The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey

Vaccine hesitancy: the next challenge in the fight against COVID-19

Attitudes Toward a Potential SARS-CoV-2 Vaccine : A Survey of U.S. Adults

Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study

Racial and ethnic differences in COVID-19 vaccine hesitancy and uptake

A future vaccination campaign against COVID-19 at risk of vaccine hesitancy and politicisation

Mistrust in biomedical research and vaccine hesitancy: the forefront challenge in the battle against COVID-19 in Italy

Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic

Effect of Information about COVID-19 Vaccine Effectiveness and Side Effects on Behavioural Intentions: Two Online Experiments

Factors predicting influenza vaccination adherence among patients in dialysis: an Italian survey